[Ocular hypertension in children treated with brimonidine 0.2%. A clinical study].
OBJECTIVE
To evaluate the safety and efficacy of topical brimonidine 0.2% use in children.


METHODS
A descriptive study of twelve successive children (21 eyes) who needed topical treatment of intraocular hypertension, and where the use of b-blockers was contraindicated.


RESULTS
During treatment we observed an average decrease of IOP of 5 SD 1.8 mmHg (21% of basal IOP), but found more common local symptoms, with stinging being complained of in 52.4% of cases. Somnolence was also complained of in two cases.
Montero-de-Espinosa
I
I
Servicio de Oftalmología, Hospital Universitario Virgen del Rocío, Sevilla, Spain. eignacio.montero.sspa@juntadeandalucia.es
Márquez-de-Aracena
R
R
Morales
C
C
D000287:Administration, Topical; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000068438:Brimonidine Tartrate; D002648:Child; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D009798:Ocular Hypertension / Q000188:drug therapy*; D011810:Quinoxalines / Q000008:administration & dosage*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D011810:Quinoxalines; D000068438:Brimonidine Tartrate